The increasing prevalence of autism spectrum disorder in Minnesota has mirrored national trends and is estimated to affect 1 out of 68 children. State legislative initiatives to screen, diagnose, and treat those with Autism spectrum disorder has reflected the steadily growing population of children who need care. Understanding how autism affects the brain can drive the development of innovative therapeutics and expand how we view and treat the disorder. Brian Trieu’s preclinical research in mice aims to understand how impaired brain systems could be reversed in autism in order to develop new therapies to restore behavioral and cognitive processes.
Graduate Fellow: Brian Trieu, Neuroscience
Mentor: Patrick Rothwell, Neuroscience